XRTX Ex-Dividend Reminder - 1/31/14

Looking at the universe of stocks we cover at Dividend Channel, on 1/31/14, Xyratex Ltd (XRTX) will trade ex-dividend, for its quarterly dividend of $0.075, payable on 2/17/14. As a percentage of XRTX's recent stock price of $13.27, this dividend works out to approximately 0.57%, so look for shares of Xyratex Ltd to trade 0.57% lower — all else being equal — when XRTX shares open for trading on 1/31/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for XRTX, showing historical dividends prior to the most recent $0.075 declared by Xyratex Ltd:

XRTX+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from XRTX is likely to continue, and whether the current estimated yield of 2.26% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of XRTX shares, versus its 200 day moving average:

Xyratex Ltd 200 Day Moving Average Chart

Looking at the chart above, XRTX's low point in its 52 week range is $8.94 per share, with $13.52 as the 52 week high point — that compares with a last trade of $13.27.

In Wednesday trading, Xyratex Ltd shares are currently off about 0.1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says